Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Calvert

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Biochemical Pharmacology|November 1, 1988
Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitroE Sikora, A L Jackman, D R Newell, et al.
Biochemistry|October 20, 1992
Structural basis for recognition of polyglutamyl folates by thymidylate synthaseA Kamb, J Finer-Moore, A H Calvert, et al.
The British Journal of Radiology|May 1, 1987
Ultrasound diagnosis of profunda femoris pseudo-aneurysm following nail-plate fixation of a transcervical femoral fractureD A Ritchie, D Hill, G M Fullarton, et al.
British Journal of Cancer|January 5, 2001
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitroK J Bowman, D R Newell, A H Calvert, et al.
Cancer Research|June 1, 1986
Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studiesA L Jackman, D L Alison, A H Calvert, et al.
British Journal of Clinical Pharmacology|February 1, 1983
Studies on the pharmacokinetics of chlorambucil and prednimustine in manD R Newell, A H Calvert, K R Harrap, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesotheliomaE K Mbidde, S J Harland, A H Calvert, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717G A Taylor, A L Jackman, A H Calvert, et al.
Lancet (London, England)|October 20, 1990
21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancerB M Cantwell, M J Millward, M J Lind, et al.
Biochemical Pharmacology|November 1, 1986
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the ratD R Newell, P M O'Connor, A H Calvert, et al.
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Biochemical Pharmacology|November 1, 1988
Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitroE Sikora, A L Jackman, D R Newell, et al.
Biochemistry|October 20, 1992
Structural basis for recognition of polyglutamyl folates by thymidylate synthaseA Kamb, J Finer-Moore, A H Calvert, et al.
The British Journal of Radiology|May 1, 1987
Ultrasound diagnosis of profunda femoris pseudo-aneurysm following nail-plate fixation of a transcervical femoral fractureD A Ritchie, D Hill, G M Fullarton, et al.
British Journal of Cancer|January 5, 2001
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitroK J Bowman, D R Newell, A H Calvert, et al.
Cancer Research|June 1, 1986
Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studiesA L Jackman, D L Alison, A H Calvert, et al.
British Journal of Clinical Pharmacology|February 1, 1983
Studies on the pharmacokinetics of chlorambucil and prednimustine in manD R Newell, A H Calvert, K R Harrap, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesotheliomaE K Mbidde, S J Harland, A H Calvert, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717G A Taylor, A L Jackman, A H Calvert, et al.
Lancet (London, England)|October 20, 1990
21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancerB M Cantwell, M J Millward, M J Lind, et al.
Biochemical Pharmacology|November 1, 1986
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the ratD R Newell, P M O'Connor, A H Calvert, et al.
Pageof 22